TCI Wealth Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-605
Closed -$4K 2358
2021
Q4
$4K Buy
605
+229
+61% +$1.59K ﹤0.01% 1851
2021
Q3
$2K Buy
+376
New +$4.24K ﹤0.01% 2151
2018
Q4
Sell
-200
Closed -$1K 1559
2018
Q3
$1K Buy
+200
New +$904 ﹤0.01% 1265
2017
Q4
Sell
-71
Closed -$1K 1402
2017
Q3
$1K Hold
71
﹤0.01% 1157
2017
Q2
$1K Buy
+71
New +$947 ﹤0.01% 1171

Other funds holding MDXG

TCI Wealth Advisors's MDXG Position: Q1 2022 in Review

TCI Wealth Advisors sold out of MiMedx Group (MDXG) in Q1 2022, closing a stake of 605 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in MDXG in Q2 2017 and held it in 5 quarters. The position peaked at $4K in Q4 2021. 150 funds tracked by Wall St. Rank hold MDXG as of Q1 2022.

  • TCI Wealth Advisors reported no remaining MiMedx Group position as of Q1 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 605 MiMedx Group shares in Q1 2022, an estimated $4K.
  • TCI Wealth Advisors first reported a position in MiMedx Group in Q2 2017 and held it in 5 quarters.
  • TCI Wealth Advisors's MiMedx Group position peaked at $4K in Q4 2021.
  • 150 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.